Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-08-09
2011-08-09
Chernyshev, Olga N (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S007210, C435S007920, C436S501000, C436S503000
Reexamination Certificate
active
07993868
ABSTRACT:
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Alzheimer's disease status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as Alzheimer's disease or non-Alzheimer's disease. The biomarkers can be detected by SELDI mass spectrometry.
REFERENCES:
patent: 5714459 (1998-02-01), O'Brien et al.
patent: WO-01/05422 (2001-01-01), None
patent: WO-03/014151 (2003-02-01), None
Chang Melissa H Y et al.: “Saposins A, B, C, and D in plasma of patients with lysosomal storage disorders” Clinical Chemistry, vol. 46, No. 2, Feb. 2000, pp. 167-174.
Fagan et al.: “The search for antecedent biomarkers of alzheimer's disease” J. Alzheimer's Dis., vol. 8, 2000, pp. 347-358.
Zhu et al.: “Cloning, Expression, and Initial Characterization of a Novel Cytokine-Like Gene Family” Genomics, vol. 80, 2002, pp. 144-150.
Carrette et al.: “A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease” Protomics, vol. 3, 2003, pp. 1486-1494.
Iguchi et al.: “Evidence for a novel pituitary protein (7B2) in human brain, cerebrospinal fluid and plasma: brain concentrations in controls and patients with Alzheimer's disease” Peptides, vol. 8, 1987, pp. 593-598.
Blennow Kaj
Davies Huw Alun
McGuire James Norton
Podust Vladimir N.
Simonsen Anja Hviid
Chernyshev Olga N
Corless Peter F.
Edwards Angell Palmer & & Dodge LLP
Hunter-Ensor, Esq. Melissa
Vermillion, Inc.
LandOfFree
Saposin D and FAM3C are biomarkers for alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Saposin D and FAM3C are biomarkers for alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Saposin D and FAM3C are biomarkers for alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2732732